Sun Pharma inks agreement to buy US-based Organon for $11.75 billion
0
Business

Sun Pharma inks agreement to buy US-based Organon for $11.75 billion

April 27, 2026
Scroll

Posted 3 hours ago by

Upon successful consummation of the transaction, Sun Pharma is poised to be among the top 25 global pharmaceutical companies with combined revenue of 12.4 billion

Sun Pharma inks agreement to buy US-based Organon for $11.75 billion
The Hindu BusinessLine
The Hindu BusinessLine

Coverage and analysis from India. All insights are generated by our AI narrative analysis engine.

India
Bias: lean right

People's Voices (0)

Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.
You might also like

Explore More